Navigation Links
Boost for Malaria Vaccine Development by Combining Strengths of Dutch and American Researchers
Date:1/16/2008

LEIDEN, The Netherlands, January 16 /PRNewswire/ -- Today Top Institute Pharma announces a highly promising research project that is aimed at the development of a malaria vaccine. This TI Pharma project will be an expansion of important findings from previous studies. The project aims to develop a highly protective malaria vaccine that would save the lives of millions of people in developing countries, especially infants and children. No malaria vaccine is currently commercially available, despite several decades of research. Multiple drugs have been developed to treat malaria infections. However, increasing numbers of both drug-resistant parasites and insecticide-resistant mosquitoes make the fight against malaria more and more difficult. As a result an efficacious vaccine is urgently needed. The United Nations recognizes this urgency and has made limiting malaria by 2015 a millennium goal.

The TI Pharma project has a budget of 16 million Euros ($US 23.6 million) over 4 years and will be carried out by a consortium that includes the American biotechnology company Sanaria Inc. of Rockville, Maryland, Radboud University Nijmegen Medical Centre and Leiden University Medical Center. Sanaria Inc. is exclusively dedicated to the production of a vaccine against malaria.

Malaria is one of the most prevalent infections in tropical and subtropical areas. The disease is caused by mosquito-transmitted protozoan parasites of the genus Plasmodium. Each year, malaria affects at least 300 million and kills at least 1 million people, principally in developing countries. Plasmodium falciparum infection produces the most lethal form of the disease and accounts for the majority of deaths.

Stephen Hoffman, CEO of Sanaria Inc. explains, "Humans are infected when malaria parasites are introduced by the bite of mosquitoes carrying these parasites. The illness results from the growth of the parasite in the blood. Sanaria's primary vaccine candidate is composed o
'/>"/>

SOURCE TI Pharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Advanced Energy Consortium will develop micro and nanosensors to boost energy production
2. Three Steps to Boost Asymchems Investment in China
3. Cystic Fibrosis: License Agreement Boosts Development of Therapy Against Lung Infections
4. New Scandinavian collaboration boosts nanotech development
5. FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir
6. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
7. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
8. Murad Boosts Skin Immunity With the New Murad(R) Professional Line
9. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
10. Kline Study: Better Brushing Habits Boost European Oral Care Sales
11. GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014  ( www.competitivehealth.com ) — Competitive Health ... bill review and advocacy service, has signed an agreement ... Savings discount health services marketplace. 63% of ... than they expected to pay. As part of an ... WellCard Savings is pleased to offer medical bill review ...
(Date:12/19/2014)... 2014 Charm Sciences is pleased to ... Detection of Aflatoxin M1 in raw commingled milk is ... party validation. The peer reviewed report of the validation ... for Agricultural and Fisheries Research (ILVO-T&V) has been published ... B1, the most toxic aflatoxin and a known carcinogen, ...
(Date:12/19/2014)... , Dec. 19, 2014 Decision Resources Group ... grow at a 12 percent compound annual growth rate ... the aging population and the increasing adoption of dental ... will also spur demand for dental biomaterials ... implant and periodontal treatments. Other key findings ...
(Date:12/19/2014)... Ed Bilsky, Ph.D., vice president for ... Excellence in the Neurosciences (CEN), and professor of pharmacology ... as a member of the prestigious Dana Alliance for ... Maine to receive this honor. , The Dana ... the Dana Foundation. Its mission is to advance ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3
... a provider of electronic parts catalogs and related technology ... and record net income for the fiscal year ended July ... million, a 2% increase from revenues of $13.4 million in ... $0.32 per diluted share, from operating income of $1.3 million ...
... and Milwaukee officials on Wednesday announced plans to launch ... network accessible to all residents. , ,The Milwaukee Wireless ... large city in America, built at no cost to ... , ,"This initiative constitutes a multi-million dollar private investment, ...
... is critical to any new medical technology or treatment's ... as determinative. , ,"Coverage" is whether there will ... is how much payment there will be if there ... analyses in their evaluation of new products and, depending ...
Cached Biology Technology:Milwaukee announces citywide wireless initiative 2On track with the FDA -- But what about your coverage and reimbursement strategy? 2On track with the FDA -- But what about your coverage and reimbursement strategy? 3On track with the FDA -- But what about your coverage and reimbursement strategy? 4
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
(Date:11/21/2014)... November 18, 2014 According to ... by Systems (Video, RFID, Access Control, Intrusion Detection, Parking ... Banks, Government), Component Service Geography - Global Forecasts to ... is projected to be around $25 Billion in 2014 ... growing at a CAGR of 8.69%. Browse ...
(Date:11/21/2014)... 2014   Atmel® Corporation (NASDAQ: ... touch technology solutions, today launched the industry,s first family ... widest V cc range from 1.7V to 5.5V. ... I 2 C bus communication speeds, and are available ... them ideal for consumer, industrial, computer, and medical applications. ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
... Neagh, has lost more than three quarters of its overwintering ... study by Quercus, Northern Ireland,s Centre for Biodiversity and Conservation ... lake for the winter months has dropped from 100,000 to ... research, published in the journal Freshwater Biology , found ...
... Munich, November 13, 2013 - Elsevier, a world-leading provider ... is pleased to announce the launch of the new ... aim of Photoacoustics is to publish original ... field of photoacoustics (optoacoustics) and thermoacoustics. Research in this ...
... , Nov. 13, 2013  Baxter International Inc. today announced ... trial of BAX 855, an investigational extended half-life, recombinant ... trial is aimed at assessing the efficacy of the ... prophylaxis and on-demand treatment schedules, and will also evaluate ...
Cached Biology News:Largest lake in Britain and Ireland has lost three-quarters of winter water birds 2Elsevier launches new open access journal: Photoacoustics 2Baxter Completes Enrollment In Phase III Clinical Trial Of BAX 855, Extended Half-life Recombinant FVIII For Hemophilia A 2Baxter Completes Enrollment In Phase III Clinical Trial Of BAX 855, Extended Half-life Recombinant FVIII For Hemophilia A 3Baxter Completes Enrollment In Phase III Clinical Trial Of BAX 855, Extended Half-life Recombinant FVIII For Hemophilia A 4Baxter Completes Enrollment In Phase III Clinical Trial Of BAX 855, Extended Half-life Recombinant FVIII For Hemophilia A 5Baxter Completes Enrollment In Phase III Clinical Trial Of BAX 855, Extended Half-life Recombinant FVIII For Hemophilia A 6
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5...
...
RayBio L Series 507: RayBio Label-based Antibody Array I (1 glass slide with 2 subarrays) Class: Antibody Array Products Product Group: Antibody Array...
Rat CXCL7/Thymus Chemokine-1 DuoSet Economy Pack, 45 Plate...
Biology Products: